Elevation Oncology Inc. (ELEV)
NASDAQ: ELEV
· Real-Time Price · USD
0.36
0.03 (8.27%)
At close: May 08, 2025, 3:59 PM
0.36
0.14%
After-hours: May 08, 2025, 07:34 PM EDT
8.27% (1D)
| Bid | 0.34 |
| Market Cap | 21.47M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -44.48M |
| EPS (ttm) | -0.78 |
| PE Ratio (ttm) | -0.46 |
| Forward PE | -0.62 |
| Analyst | Hold |
| Ask | 0.37 |
| Volume | 517,577 |
| Avg. Volume (20D) | 1,454,416 |
| Open | 0.34 |
| Previous Close | 0.33 |
| Day's Range | 0.33 - 0.36 |
| 52-Week Range | 0.22 - 4.33 |
| Beta | 1.61 |
About ELEV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELEV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELEV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-41.82%
Elevation Oncology shares are trading lower after ...
Unlock content with
Pro Subscription
3 months ago
+10.79%
Elevation Oncology shares are trading higher after the company announced it advanced its EO-3021 trial to target advanced gastric and GEJ cancers with improved care.
